These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 36540802)

  • 21. Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors.
    Pu D; Xu Q; Zhou LY; Zhou YW; Liu JY; Ma XL
    Thorac Cancer; 2021 Nov; 12(21):2914-2923. PubMed ID: 34581010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer.
    Hu YX; Guo LJ; Lin MQ; Lin QY
    Am J Clin Oncol; 2023 Apr; 46(4):161-166. PubMed ID: 36806256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a nomogram model for predicting venous thromboembolism risk in lung cancer patients treated with immune checkpoint inhibitors: A cohort study in China.
    Liang G; Hu Z; Xu Q; Wang G; Wang Y; Li X; Zhang W; Lei H
    Cancer Med; 2024 Aug; 13(16):e70115. PubMed ID: 39162396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.
    Li Y; Wang K; Zhao E; Li B; Li S; Dong X; Yuan L; Yang H
    Pathol Oncol Res; 2022; 28():1610245. PubMed ID: 35721326
    [No Abstract]   [Full Text] [Related]  

  • 25. Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population-based analysis.
    Zhao J; Li D; Xie S; Deng X; Wen X; Li J; Wu Z; Yang X; Li M; Tang Y; Zhang X; Ding Y
    Front Immunol; 2022; 13():1083840. PubMed ID: 36618343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
    Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
    Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
    Pietrantonio F; Lonardi S; Corti F; Infante G; Elez ME; Fakih M; Jayachandran P; Shah AT; Salati M; Fenocchio E; Salvatore L; Curigliano G; Cremolini C; Ambrosini M; Ros J; Intini R; Nappo F; Damian S; Morano F; Fucà G; Overman M; Miceli R
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34429334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study.
    Wen S; Du X; Chen Y; Xia J; Wang R; Zhu M; Peng W; Spitaleri G; Hofman P; Bironzo P; Wang X; Shen B
    Transl Lung Cancer Res; 2022 May; 11(5):757-775. PubMed ID: 35693285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
    Hu X; Xu H; Xue Q; Wen R; Jiao W; Tian K
    Mol Med; 2021 Oct; 27(1):126. PubMed ID: 34620079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.
    Mezquita L; Auclin E; Ferrara R; Charrier M; Remon J; Planchard D; Ponce S; Ares LP; Leroy L; Audigier-Valette C; Felip E; Zerón-Medina J; Garrido P; Brosseau S; Zalcman G; Mazieres J; Caramela C; Lahmar J; Adam J; Chaput N; Soria JC; Besse B
    JAMA Oncol; 2018 Mar; 4(3):351-357. PubMed ID: 29327044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study.
    Zhang W; Li S; Zhang C; Mu Z; Chen K; Xu Z
    Acta Oncol; 2023 Aug; 62(8):853-860. PubMed ID: 37377003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.
    Yuan S; Xia Y; Shen L; Ye L; Li L; Chen L; Xie X; Lou H; Zhang J
    Cancer Immunol Immunother; 2021 Feb; 70(2):533-546. PubMed ID: 32852602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel lactate dehydrogenase-based risk score model to predict the prognosis of primary central nervous system germ cell tumor treated with chemoradiotherapy.
    Yao DC; Ye BK; Yao DJ; Guo CC
    Clin Neurol Neurosurg; 2024 Jan; 236():108081. PubMed ID: 38091701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters.
    Jia G; Qiu L; Zheng H; Qin B; Sun Z; Shao Y; Yang Z; Shao J; Zhou Y; Jiao S
    BMC Cancer; 2023 Jun; 23(1):556. PubMed ID: 37328805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.
    Zhao Q; Li B; Xu Y; Wang S; Zou B; Yu J; Wang L
    Cancer Med; 2021 Sep; 10(18):6291-6303. PubMed ID: 34390218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A prognostic nomogram for metastasized colorectal cancer patients treated with cetuximab].
    Zhong LP; Li D; Zhu LZ; Fang XF; Xiao Q; Ding KF; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):701-708. PubMed ID: 32683833
    [No Abstract]   [Full Text] [Related]  

  • 40. A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients.
    Chen L; Dhoomun DK; Liu Q; Kong X; Li X; Peng S; Lan P; Wang J
    Int Immunopharmacol; 2024 Aug; 137():112411. PubMed ID: 38852520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.